...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Cardiovascular Journal >Prognostic Value of NT-proBNP in Predicting Adverse In-hospital Outcomes among Patients of STEMI getting Thrombolytic therapy without Clinical Manifestation of Heart Failure
【24h】

Prognostic Value of NT-proBNP in Predicting Adverse In-hospital Outcomes among Patients of STEMI getting Thrombolytic therapy without Clinical Manifestation of Heart Failure

机译：NT-proBNP在预测溶栓治疗而无心衰临床表现的STEMI患者中院内不良预后的预后价值

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: Risk stratification is extremely important in ACS patients especially acute STEMI. We studied in-hospital outcomes of acute STEMI according to their NT-proBNP level as a new prognostic marker.Methods: This observational prospective study was conducted to evaluate the significance of raised plasma NT-proBNP level on in-hospital outcomes in patients with STEMI, without clinical manifestation of heart failure. A total 88 patients of STEMI were included in the study. Among them 10 Patients have normal levels of NT-proBNP (<110 pg/ml) and were included in Group-A (n = 10). Patients with increased proBNP level (e”110 pg/ml) were included in Group-B (n = 78). Patients were followed to see worse in-hospital outcomes (Heart failure, cardiogenic shock, significant arrhythmia and death) during index hospitalization period.Results: Plasma NT-proBNP level was observed to be significantly higher among patients who developed heart failure, cardiogenic shock and death than the patients who did not developed these outcome (p < 0.001). The binary logistic regression analysis of Odds Ratios for characteristics of the patients likely to cause worse in-hospital outcome shows that NT-ProBNP and smoking habit were found to be the independent predictors of worse in-hospital outcome with ORs being 5.0 and 4.7 respectively.Conclusion: On admission plasma NT-pro BNP level in patients with STEMI is a strong independent predictor of adverse in-hospital outcome.Cardiovasc. j. 2017; 10(1): 8-12
机译：背景：风险分层对于ACS患者尤其是急性STEMI患者极为重要。我们根据其NT-proBNP水平作为新的预后标志物研究了急性STEMI的院内预后。方法：这项观察性前瞻性研究旨在评估血浆NT-proBNP水平升高对STEMI患者的院内预后的意义。 ，无心力衰竭的临床表现。该研究共纳入88名STEMI患者。其中10例患者的NT-proBNP水平正常（<110 pg / ml），被纳入A组（n = 10）。 proBNP水平升高（e” 110 pg / ml）的患者被纳入B组（n = 78）。结果：在发生心力衰竭，心源性休克和心律失常的患者中，血浆NT-proBNP水平显着升高，患者在住院期间的院内预后较差（心力衰竭，心源性休克，明显的心律失常和死亡）。死亡的患者比未取得这些预后的患者高（p <0.001）。可能导致住院结局恶化的患者特征的比值比值的二进制logistic回归分析表明，NT-ProBNP和吸烟习惯是院内结局恶化的独立预测因子，OR分别为5.0和4.7。结论：STEMI患者入院时血浆NT-pro BNP水平是院内不良预后的有力独立预测指标。 j。 2017; 10（1）：8-12

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号